{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:27:03Z","timestamp":1791653223125,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd008117","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000}}],"reference-count":63,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008117.pub2","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T02:51:37Z","timestamp":1391223097000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacological interventions for hypertension in children"],"prefix":"10.1002","volume":"2014","author":[{"given":"Swasti","family":"Chaturvedi","sequence":"first","affiliation":[{"name":"Christian Medical College; Department of Paediatrics; Ida Scudder Road Vellore Tamil Nadu India 632004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah H","family":"Lipszyc","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children; Institute of Medical Science; University of Toronto 555 University Avenue Toronto ON Canada M5G 1X8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Licht","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children; Department of Nephrology; 555 University Avenue Toronto ON Canada M5G 1X8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulan","family":"Parekh","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children; Department of Paediatrics; Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,2,1]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2006.09.034","article-title":"Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience","volume":"150","author":"Batisky","year":"2007","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0002|cit2","unstructured":"Bristol-Meyers Squibb United States Food and Drug Administration. Summaries of Medical and Clinical Pharmacology Reviews http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/ucm161894.htm 2005"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.83.2.425","article-title":"Use of clonidine monotherapy (versus diuretics) in adolescent hypertension","volume":"83","author":"Falkner","year":"1983","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD008117.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jpeds.2004.04.009","article-title":"A randomized, placebo-controlled trial of amlodipine in children with hypertension","volume":"145","author":"Flynn","year":"2004","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/HYPERTENSIONAHA.108.111054","article-title":"Efficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years","volume":"52","author":"Flynn","year":"2008","journal-title":"Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD008117.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00238.x","article-title":"Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood","volume":"64","author":"Gartenmann","year":"2003","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0008|cit7","unstructured":"Hazan L Personal correspondence October 2010"},{"issue":"6","key":"10.1002\/14651858.CD008117.pub2-BIB0007|cit8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/HYPERTENSIONAHA.109.147702","article-title":"A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension","volume":"55","author":"Hazan","year":"2010","journal-title":"Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD008117.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/HYPERTENSIONAHA.109.147702","article-title":"A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension","volume":"55","author":"Hazan","year":"2010","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0011|cit10","unstructured":"Li JS Personal communication"},{"issue":"3","key":"10.1002\/14651858.CD008117.pub2-BIB0010|cit11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/01.HYP.0000138069.68413.f0","article-title":"Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?","volume":"44","author":"Li","year":"2004","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0012|cit12","doi-asserted-by":"crossref","unstructured":"Li JS Flynn JT Portman R Davis I Ogawa M Shi H Pressler ML The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose-response study Journal of Pediatrics 2010 282 7","DOI":"10.1016\/j.jpeds.2010.02.042"},{"issue":"5","key":"10.1002\/14651858.CD008117.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/HJH.0b013e328336b86b","article-title":"Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age","volume":"28","author":"Schaefer","year":"2010","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1097\/HJH.0b013e32834c625c","article-title":"Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study","volume":"29","author":"Schaefer","year":"2011","journal-title":"Journal of Hypertension"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD008117.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjhyper.2004.09.009","article-title":"A double-blind, dose-response study of losartan in hypertensive children","volume":"18","author":"Shahinfar","year":"2005","journal-title":"American Journal of Hypertension"},{"issue":"10","key":"10.1002\/14651858.CD008117.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0895-7061(03)00900-2","article-title":"A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension","volume":"16","author":"Soffer","year":"2003","journal-title":"American Journal of Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD008117.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00467-002-0851-0","article-title":"Beta-blocker\/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial","volume":"17","author":"Sorof","year":"2002","journal-title":"Pediatric Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD008117.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00467-003-1134-0","article-title":"Clinical trial of extended-release felodipine in pediatric essential hypertension","volume":"18","author":"Trachtman","year":"2003","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0020|cit19","unstructured":"Trachtman H Personal communication April 2010"},{"issue":"10","key":"10.1002\/14651858.CD008117.pub2-BIB0019|cit20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1751-7176.2008.00022.x","article-title":"Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years","volume":"10","author":"Trachtman","year":"2008","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2215\/CJN.06620909","article-title":"Randomized, double-blind, controlled study of losartan in children with proteinuria","volume":"5","author":"Webb","year":"2010","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD008117.pub2-BIB0022|cit22","first-page":"1636","article-title":"An open-label dose-response study of losartan in hypertensive children","volume":"28","author":"Webb","year":"2013","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD008117.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/009127002401102786","article-title":"A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension","volume":"42","author":"Wells","year":"2002","journal-title":"Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1002\/14651858.CD008117.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1177\/0009922810363609","article-title":"Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension","volume":"49","author":"Wells","year":"2010","journal-title":"Clinical Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD008117.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1751-7176.2011.00432.x","article-title":"Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension","volume":"13","author":"Wells","year":"2011","journal-title":"Journal of Clinical Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD008117.pub2-BIB0026|cit26","first-page":"55","article-title":"Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension","volume":"39","author":"Bachmann","year":"1984","journal-title":"Helvetica Paediatrica Acta"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00000441-199002000-00001","article-title":"Combined low-dose medication and primary intervention over a 30-month period for sustained high blood pressure in childhood","volume":"299","author":"Berenson","year":"1990","journal-title":"American Journal of the Medical Sciences"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/archdischild-2011-301305","article-title":"Dark chocolate for children\u2019s blood pressure: randomised trial","volume":"97","author":"Chan","year":"2012","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0029|cit29","first-page":"119","article-title":"Evaluation of the efficacy and tolerance of three antihypertensive agents used as single-drug therapy, nifedipine, prazosin and acebutolol in severe, idiopathic hypertension in adolescents","volume":"40","author":"Cichocka","year":"1993","journal-title":"Annales de Pediatrie"},{"issue":"10","key":"10.1002\/14651858.CD008117.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0895-7061(04)00875-1","article-title":"Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders","volume":"17","author":"Ellis","year":"2004","journal-title":"American Journal of Hypertension"},{"issue":"8","key":"10.1002\/14651858.CD008117.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD008117.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0022-3476(80)80038-2","article-title":"Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension","volume":"97","author":"Friedman","year":"1980","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1751-7176.2011.00502.x","article-title":"The efficacy and safety of valsartan in obese and non-obese pediatric hypertensive patients","volume":"13","author":"Meyers","year":"2011","journal-title":"Journal of Clinical Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/adc.73.2.154","article-title":"A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension","volume":"73","author":"Moncica","year":"1995","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1651-2227.1992.tb12191.x","article-title":"Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis","volume":"81","author":"Morsi","year":"1992","journal-title":"Acta Paediatrica"},{"issue":"12","key":"10.1002\/14651858.CD008117.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s004670000400","article-title":"A randomized prospective crossover trial of amlodipine in pediatric hypertension","volume":"14","author":"Rogan","year":"2000","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008117.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3476(77)80466-6","article-title":"Management of severe childhood hypertension with minoxidil: a controlled clinical study","volume":"91","author":"Sinaiko","year":"1977","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD008117.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0022-3476(83)80490-9","article-title":"Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease","volume":"103","author":"Sinaiko","year":"1983","journal-title":"Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD008117.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00467-003-1190-5","article-title":"Antiproteinuric effects of enalapril and losartan: a pilot study","volume":"18","author":"White","year":"2003","journal-title":"Pediatric Nephrology"},{"issue":"17","key":"10.1002\/14651858.CD008117.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD008117.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00246-006-1390-4","article-title":"Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension","volume":"28","author":"Assadi","year":"2007","journal-title":"Pediatric Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD008117.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.107.108886","article-title":"Pediatric antihypertensive trial failures: analysis of end points and dose range","volume":"51","author":"Benjamin","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/17477160600761068","article-title":"Marked increase in the prevalence of obesity in children of the Seychelles, a rapidly developing country, between 1998 and 2004","volume":"1","author":"Bovet","year":"2006","journal-title":"International Journal of Pediatric Obesity"},{"issue":"19","key":"10.1002\/14651858.CD008117.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD008117.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jpeds.2007.09.022","article-title":"The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure","volume":"152","author":"Couch","year":"2008","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0002-9394(14)72260-3","article-title":"The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension","volume":"111","author":"Daniels","year":"1991","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00431-003-1376-7","article-title":"The outcome of childhood obesity management depends highly upon patient compliance","volume":"163","author":"Denzer","year":"2004","journal-title":"European Journal of Pediatrics"},{"issue":"13","key":"10.1002\/14651858.CD008117.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1161\/CIRCULATIONAHA.106.683243","article-title":"High blood pressure trends in children and adolescents in national surveys, 1963 to 2002","volume":"116","author":"Din-Dzietham","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/FJC.0b013e31820d1b89","article-title":"Management of hypertension in the young: role of antihypertensive medications","volume":"58","author":"Flynn","year":"2011","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0053|cit53","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1542\/peds.67.2.255","article-title":"Left ventricular hypertrophy in adolescents with elevated blood pressure: assessment by chest roentgenography, electrocardiography, and echocardiography","volume":"67","author":"Laird","year":"1981","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008117.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.HYP.0000227029.10536.e8","article-title":"Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study","volume":"48","author":"Lande","year":"2006","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archpediatrics.2009.5","article-title":"Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents","volume":"163","author":"Liberman","year":"2009","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0057|cit57","first-page":"110","article-title":"Hypertension in children and adolescents \u2013 diagnostic challenges and management","volume":"6","author":"Lipszyc","year":"2011","journal-title":"US Nephrol"},{"issue":"2","key":"10.1002\/14651858.CD008117.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/HYPERTENSIONAHA.107.092197","article-title":"Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria","volume":"50","author":"McNiece","year":"2007","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","journal-title":"Pediatrics"},{"issue":"13","key":"10.1002\/14651858.CD008117.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999-2004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0061|cit61","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"1","key":"10.1002\/14651858.CD008117.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1542\/peds.111.1.61","article-title":"Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure","volume":"111","author":"Sorof","year":"2003","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008117.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/11586670-000000000-00000","article-title":"The correct administration of antihypertensive drugs according to the principles of clinical pharmacology","volume":"11","author":"Taddei","year":"2011","journal-title":"American Journal of Cardiovascular Drugs"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008117.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T19:22:03Z","timestamp":1714332123000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008117.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,1]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008117.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,1]]}}}